Optimum Strategic Communications and Bloomberg Intelligence partner to debate the Future of Healthcare

Optimum Strategic Communications and Bloomberg Intelligence partner to debate the Future of Healthcare

10th Annual Healthcare Investor conference
Expert panellists include public, private investors and leading European companies

12 October 2018, London, UK: Optimum Strategic Communications (Optimum), the international strategic healthcare communications firm, will be hosting its 10th Annual Healthcare Investor Conference in partnership with Bloomberg Intelligence on Tuesday, 16 October 2018.

The conference, now in its 10th successful year, brings together the top executives and visionaries from the healthcare industry and the investment community to discuss and debate the latest trends set to reshape the industry far into the future. This year’s theme, The Future of Healthcare looks at the impact of tech on healthcare, what is attracting early stage investment, how the public markets are shaping up and the next ‘big thing’ to disrupt the sector. The conference will take place at Bloomberg’s new European Headquarters in London.

Mary Clark, Managing Director, Optimum Strategic Communications, commented on the event:

“Ten years ago, we held our first annual investor conference with the aim of providing a forum for our client companies, investors focused on healthcare and analysts covering the sector, to come together to discuss and debate issues and trends that will have a major impact on our industry far into the future. I am delighted that ten years on, our event is now part of a thriving ecosystem and is firmly established as the leading healthcare investor conference in Europe.

“This year’s conference agenda is one of our best yet. We are privileged to have hosted fantastic speakers from industry and the investment community over the years and this year, once again, we have a superb line up. Our esteemed panellists and speakers are keen to share their insight and experience, and as always make for a spirited discussion.”

The conference starts with a fireside chat between Kasim Kutay, CEO of Novo Holdings and Dan Mahony, Fund Manager, Polar Capital discussing the trends shaping the healthcare sector.

Clive Cookson from the Financial Times will be chairing the discussion on Health Tech – How is Tech transforming developments in healthcare? Is it analysing patient data, accelerating drug discovery and product development? Which companies and sectors stand to benefit most from the tech-driven transformation in healthcare? And which are at risk of losing out? We are hearing more and more about AI in the healthcare context. How much is hype and how much will AI be transformative? How should investors make the most of what is to come?

Mike Ward of Scrip Intelligence / Informa Group will lead the panel of the largest and most influential healthcare private investors Accelerating future developments – what is attracting private investment? The panel will discuss what is attracting investment and how they identify transformative treatments.

Sam Fazeli, Director of EMEA Research, Bloomberg Intelligence, speaks to Simon Moroney, CEO of Morphosys, one of the longest serving and successful CEOs in the industry, to discuss how to build a successful biotech in Europe.

The final panel of the day, Investor Question Time, is a debate between the buy-side investors and sell-side analysts that invest and cover the healthcare sector. Chaired by Werner Lanthaler, CEO of Evotec, the panel will discuss companies ahead of investing, what has changed after MiFid II and the importance of Environmental, Societal and Governance factors in the investment process.

Mary Clark added:

“We are also celebrating our first year as Optimum Strategic Communications. We have had a brilliant first year and I am very proud of what we have achieved. We have worked with businesses across the whole healthcare sector, advised on one of the largest M&A transactions in the sector, supported IPOs across different European exchanges, significant fund raisings and launched the next generation of biotech companies.”

The detailed agenda can be found here.

– ENDS –

If you would like to receive summaries of the panel discussions at the conference or speak with the Optimum team, please email contact@optimumcomms.com.


Kasim Kutay, Novo Holdings
Dan Mahony, Polar Capital
Clive Cookson, Science Editor, Financial Times
Paul Major, Bellevue Asset Management
Jackie Hunter, BenevolentAI
Andrew Hopkins, Exscientia
Tony Young, NHS England
Mike Ward, Scrip Intelligence/Informa Group
Ed Rayner, Arix Bioscience plc
Roel Bulthuis, M Ventures
Bali Muralidhar, MVM Life Science Partners
Annalisa Jenkins, PlaqueTec
Thomas Burt, Sofinnova
Simon Moroney, Morphosys
Werner Lanthaler, Evotec
Linden Thomson, AXA Investment Managers
Charles Weston, Berenberg
Gavin MacGregor, HBM Partners
Vicky Darbyshire, JP Morgan Asset Management
Ilan Chaitowitz, Nomura Asset Management
Mary Clark, Optimum Strategic Communications
Sam Fazeli, Bloomberg Intelligence

For further information:

Optimum Strategic Communications
Supriya Mathur, Hollie Vile
Email: contact@optimumcomms.com
Tel: T: +44 (0) 203 922 0891
Twitter: @OptimumComms
LinkedIn: optimum-strategic-communications

About Optimum Strategic Communications
Optimum is an international strategic healthcare communications firm, based in London and New York, which specialises in investor relations, corporate and financial communications. Our senior team of healthcare specialists are experienced and trusted advisors to some of the world’s most exciting public and private companies, both large and small, across pharmaceuticals, medtech, biotech, health tech and healthcare services.

Over the last 20 years we have worked with over 200 healthcare companies, advising them on financial communications and investor relations, including major corporate activity such as fundraising, IPOs, and M&A, as well as corporate reputation and crisis scenarios.

We have an exceptional network of contacts across the international investment community in Europe and the US; contacts we have built and maintained over the last two decades. Our team includes ex-fund managers and analysts.

We specialise in developing clear outcome driven strategies with tailored communications programmes to help clients achieve their business goals. Our experience of analysing, investing and writing about healthcare companies uniquely enables us to help our clients build a compelling investment story. While our knowledge of the global healthcare industry, combined with in-depth research and analysis, enables us to provide our clients with informed and creative advice.

Optimum is partnered with Euronext on the TechShare project, the only European programme for non-listed companies dedicated to IPOs. The programme is an educational network designed to help high-potential businesses understand the role of capital markets and how they can help them reach the next stage of their growth. Optimum will be providing IR coaching to companies looking to list on Euronext.

For more information please visit www.optimumcomms.com